{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:46:11Z","timestamp":1790189171935,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00115-025-01914-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:02:08Z","timestamp":1762516928000},"page":"715-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Update Tic-St\u00f6rungen und Tourette-Syndrom","Update on tic disorders and Tourette syndrome"],"prefix":"10.1007","volume":"96","author":[{"given":"Juan Carlos","family":"Baldermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Rolker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00fcller-Vahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"publisher","first-page":"1504442","DOI":"10.3389\/fpsyt.2025.1504442","volume":"16","author":"JB Wohlgemuth","year":"2025","unstructured":"Wohlgemuth\u00a0JB, Watson\u00a0KH, Gill\u00a0KD, Isaacs\u00a0DA (2025) Premonitory urge in tic disorders\u2014a\u00a0scoping review. Front Psychiatry 16:1504442","journal-title":"Front Psychiatry"},{"issue":"8","key":"1914_CR2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/mdc3.70078","volume":"12","author":"T Grippe","year":"2025","unstructured":"Grippe\u00a0T, Lang\u00a0A, Ganos\u00a0C (2025) Mov Disord Clin Pract 12(8):1220\u20131221","journal-title":"Mov Disord Clin Pract"},{"key":"1914_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14802\/jmd.21045","volume":"15","author":"J Essing","year":"2022","unstructured":"Essing\u00a0J, Jakubovski\u00a0E, Psathakis\u00a0N, Cevirme\u00a0SN, Leckman\u00a0JF, M\u00fcller-Vahl\u00a0KR (2022) Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders. J\u00a0Mov Disord 15:43\u201352","journal-title":"J Mov Disord"},{"key":"1914_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00787-018-01272-7","volume":"28","author":"KR M\u00fcller-Vahl","year":"2019","unstructured":"M\u00fcller-Vahl\u00a0KR, Sambrani\u00a0T, Jakubovski\u00a0E (2019) Tic disorders revisited: introduction of the term \u201ctic spectrum disorders\u201d. Eur Child Adolesc Psychiatry 28:1129\u20131135","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1914_CR5","doi-asserted-by":"publisher","first-page":"152510","DOI":"10.1016\/j.comppsych.2024.152510","volume":"134","author":"SC Grossen","year":"2024","unstructured":"Grossen\u00a0SC, Arbuckle\u00a0AL, Bihun\u00a0EC, Koller\u00a0JM, Song\u00a0DY, Reiersen\u00a0AM et\u00a0al (2024) We\u2019ve all been wrong about provisional tic disorder. Compr Psychiatry 134:152510","journal-title":"Compr Psychiatry"},{"key":"1914_CR6","unstructured":"https:\/\/www.bfarm.de\/DE\/Kodiersysteme\/Klassifikationen\/ICD\/ICD-11\/uebersetzung\/_node.html. Zugegriffen: 29. Juli 2025"},{"key":"1914_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","volume":"47","author":"T Knight","year":"2012","unstructured":"Knight\u00a0T, Steeves\u00a0T, Day\u00a0L, Lowerison\u00a0M, Jette\u00a0N, Pringsheim\u00a0T (2012) Prevalence of tic disorders: a\u00a0systematic review and meta-analysis. Pediatr Neurol 47:77\u201390","journal-title":"Pediatr Neurol"},{"key":"1914_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jaac.2017.01.010","volume":"56","author":"C Groth","year":"2017","unstructured":"Groth\u00a0C, Mol Debes\u00a0N, Rask\u00a0CU, Lange\u00a0T, Skov\u00a0L (2017) Course of Tourette Syndrome and Comorbidities in a\u00a0Large Prospective Clinical Study. J\u00a0Am Acad Child Adolesc Psychiatry 56:304\u2013312","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1914_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/mp.2017.31","volume":"23","author":"G Brander","year":"2018","unstructured":"Brander\u00a0G, Rydell\u00a0M, Kuja-Halkola\u00a0R, Fern\u00e1ndez de la Cruz\u00a0L, Lichtenstein\u00a0P, Serlachius\u00a0E et\u00a0al (2018) Perinatal risk factors in Tourette\u2019s and chronic tic disorders: a\u00a0total population sibling comparison study. Mol Psychiatry 23:1189\u20131197","journal-title":"Mol Psychiatry"},{"key":"1914_CR10","first-page":"821","volume":"109","author":"AG Ludolph","year":"2012","unstructured":"Ludolph\u00a0AG, Roessner\u00a0V, M\u00fcnchau\u00a0A, M\u00fcller-Vahl\u00a0K (2012) Tourette Syndrome and Other Tic Disorders in Childhood, Adolescence and Adulthood. Dtsch \u00c4rztebl Int 109:821\u2013828","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1914_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","volume":"176","author":"D Yu","year":"2019","unstructured":"Yu\u00a0D, Sul\u00a0JH, Tsetsos\u00a0F, Nawaz\u00a0MS, Huang\u00a0AY, Zelaya\u00a0I et\u00a0al (2019) Interrogating the Genetic Determinants of Tourette\u2019s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. Am J Psychiatry 176:217\u2013227","journal-title":"Am J Psychiatry"},{"key":"1914_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.neuron.2017.04.024","volume":"94","author":"AJ Willsey","year":"2017","unstructured":"Willsey\u00a0AJ, Fernandez\u00a0TV, Yu\u00a0D, King\u00a0RA, Dietrich\u00a0A, Xing\u00a0J et\u00a0al (2017) De Novo Coding Variants Are Strongly Associated with Tourette Disorder. Neuron 94:486\u2013499.e9","journal-title":"Neuron"},{"key":"1914_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12888-018-1822-8","volume":"18","author":"K Nickel","year":"2018","unstructured":"Nickel\u00a0K, Tebartz van Elst\u00a0L, Domschke\u00a0K, Gl\u00e4ser\u00a0B, Stock\u00a0F, Endres\u00a0D et\u00a0al (2018) Heterozygous deletion of SCN2A and SCN3A in a\u00a0patient with autism spectrum disorder and Tourette syndrome: a\u00a0case report. BMC Psychiatry 18:248","journal-title":"BMC Psychiatry"},{"key":"1914_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.conb.2017.08.009","volume":"46","author":"VA Concei\u00e7\u00e3o","year":"2017","unstructured":"Concei\u00e7\u00e3o\u00a0VA, Dias \u00c2, Farinha\u00a0AC, Maia\u00a0TV (2017) Premonitory urges and tics in Tourette syndrome: computational mechanisms and neural correlates. Curr Opin Neurobiol 46:187\u2013199","journal-title":"Curr Opin Neurobiol"},{"key":"1914_CR15","doi-asserted-by":"publisher","first-page":"10687","DOI":"10.1038\/s41467-024-55242-6","volume":"15","author":"JC Baldermann","year":"2024","unstructured":"Baldermann\u00a0JC, Petry-Schmelzer\u00a0JN, Sch\u00fcller\u00a0T, Mahfoud\u00a0L, Brandt\u00a0GA, Dembek\u00a0TA et\u00a0al (2024) A critical role of action-related functional networks in Gilles de la Tourette syndrome. Nat Commun 15:10687","journal-title":"Nat Commun"},{"key":"1914_CR16","doi-asserted-by":"publisher","first-page":"13307","DOI":"10.1073\/pnas.0502624102","volume":"102","author":"PSA Kalanithi","year":"2005","unstructured":"Kalanithi\u00a0PSA, Zheng\u00a0W, Kataoka\u00a0Y, DiFiglia\u00a0M, Grantz\u00a0H, Saper\u00a0CB et\u00a0al (2005) Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci 102:13307\u201313312","journal-title":"Proc Natl Acad Sci"},{"key":"1914_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","volume":"72","author":"ME Hirschtritt","year":"2015","unstructured":"Hirschtritt\u00a0ME, Lee\u00a0PC, Pauls\u00a0DL, Dion\u00a0Y, Grados\u00a0MA, Illmann\u00a0C et\u00a0al (2015) Lifetime Prevalence, Age of Risk, and Genetic Relationships of Comorbid Psychiatric Disorders in Tourette Syndrome. JAMA Psychiatry 72:325","journal-title":"JAMA Psychiatry"},{"key":"1914_CR18","doi-asserted-by":"publisher","first-page":"578654","DOI":"10.1016\/j.jneuroim.2025.578654","volume":"406","author":"D Endres","year":"2025","unstructured":"Endres\u00a0D, von Zedtwitz\u00a0K, Rau\u00a0A, Feige\u00a0B, Mast\u00a0H, Maier\u00a0A et\u00a0al (2025) Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluid. J\u00a0Neuroimmunol 406:578654","journal-title":"J Neuroimmunol"},{"key":"1914_CR19","doi-asserted-by":"publisher","first-page":"e1680","DOI":"10.1212\/WNL.0000000000011610","volume":"96","author":"D Martino","year":"2021","unstructured":"Martino\u00a0D, Schrag\u00a0A, Anastasiou\u00a0Z, Apter\u00a0A, Benaroya-Milstein\u00a0N, Buttiglione\u00a0M et\u00a0al (2021) Association of Group\u00a0A Streptococcus Exposure and Exacerbations of Chronic Tic Disorders: A\u00a0Multinational Prospective Cohort Study. Neurology 96:e1680\u2013e1693","journal-title":"Neurology"},{"key":"1914_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/mdc3.13977","volume":"11","author":"C Nilles","year":"2024","unstructured":"Nilles\u00a0C, Martino\u00a0D, Berg\u00a0L, Fletcher\u00a0J, Pringsheim\u00a0T (2024) What are the Key Phenomenological Clues to Diagnose Functional Tic-Like Behaviors in the Pandemic Era? Mov Disord Clin Pract 11:398\u2013402","journal-title":"Mov Disord Clin Pract"},{"key":"1914_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","volume":"20","author":"V Roessner","year":"2011","unstructured":"Roessner\u00a0V, Plessen\u00a0KJ, Rothenberger\u00a0A et\u00a0al (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part\u00a0II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173\u2013196. https:\/\/doi.org\/10.1007\/s00787-011-0163-7","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00787-021-01899-z","volume":"31","author":"V Roessner","year":"2022","unstructured":"Roessner\u00a0V, Eichele\u00a0H, Stern\u00a0JS, Skov\u00a0L, Rizzo\u00a0R, Debes\u00a0NM et\u00a0al (2022) European clinical guidelines for Tourette syndrome and other tic disorders\u2014version\u00a02.0. Part\u00a0III: pharmacological treatment. Eur Child Adolesc Psychiatry 31:425\u2013441","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1914_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0005-7967(03)00154-2","volume":"42","author":"CWJ Verdellen","year":"2004","unstructured":"Verdellen\u00a0CWJ, Keijsers\u00a0GPJ, Cath\u00a0DC, Hoogduin\u00a0CAL (2004) Exposure with response prevention versus habit reversal in Tourettes\u2019s syndrome: a\u00a0controlled study. Behav Res Ther 42:501\u2013511","journal-title":"Behav Res Ther"},{"key":"1914_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/cap.2016.0026","volume":"27","author":"F Sallee","year":"2017","unstructured":"Sallee\u00a0F, Kohegyi\u00a0E, Zhao\u00a0J, McQuade\u00a0R, Cox\u00a0K, Sanchez\u00a0R et\u00a0al (2017) Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette\u2019s Disorder in Children and Adolescents. J\u00a0Child Adolesc Psychopharmacol 27:771\u2013781","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1914_CR25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00228-024-03710-9","volume":"80","author":"I Serag","year":"2024","unstructured":"Serag\u00a0I, Elsakka\u00a0MM, din Moawad\u00a0MHE, Ali\u00a0HT, Sarhan\u00a0K, Shayeb\u00a0S et\u00a0al (2024) Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a\u00a0systematic review and meta-analysis. Eur J Clin Pharmacol 80:1483\u20131493","journal-title":"Eur J Clin Pharmacol"},{"key":"1914_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00787-021-01832-4","volume":"31","author":"KR M\u00fcller-Vahl","year":"2022","unstructured":"M\u00fcller-Vahl\u00a0KR, Szejko\u00a0N, Verdellen\u00a0C, Roessner\u00a0V, Hoekstra\u00a0PJ, Hartmann\u00a0A et\u00a0al (2022) European clinical guidelines for Tourette syndrome and other tic disorders: summary statement. Eur Child Adolesc Psychiatry 31:377\u2013382","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1914_CR27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00787-024-02637-x","volume":"34","author":"A H\u00e4ge","year":"2025","unstructured":"H\u00e4ge\u00a0A, Kr\u00e4mer\u00a0R, Dunlap\u00a0M, Mechler\u00a0K, M\u00fcller-Vahl\u00a0KR, Nagy\u00a0P (2025) Emerging therapeutic approaches for Tourette syndrome and other tic disorders\u2014a\u00a0systematic review of current clinical trials. Eur Child Adolesc Psychiatry 34:1719\u20131729","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1914_CR28","doi-asserted-by":"publisher","first-page":"769275","DOI":"10.3389\/fneur.2021.769275","volume":"12","author":"L Wehmeyer","year":"2021","unstructured":"Wehmeyer\u00a0L, Sch\u00fcller\u00a0T, Kiess\u00a0J, Heiden\u00a0P, Visser-Vandewalle\u00a0V, Baldermann\u00a0JC et\u00a0al (2021) Target-Specific Effects of Deep Brain Stimulation for Tourette Syndrome: A\u00a0Systematic Review and Meta-Analysis. Front Neurol 12:769275","journal-title":"Front Neurol"},{"key":"1914_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/cap.2024.0049","volume":"34","author":"LC Farhat","year":"2024","unstructured":"Farhat\u00a0LC, Behling\u00a0E, Landeros-Weisenberger\u00a0A, Macul Ferreira de Barros\u00a0P, Polanczyk\u00a0GV, Cortese\u00a0S et\u00a0al (2024) Pharmacological Interventions for Attention-Deficit\/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A\u00a0Systematic Review and Network Meta-Analysis. J\u00a0Child Adolesc Psychopharmacol 34:373\u2013382","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01914-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:03:13Z","timestamp":1764374593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01914-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01914-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"J.C.\u00a0Baldermann\n                      : A.\u00a0Finanzielle Interessen: Deutsche Forschungsgemeinschaft (DFG) SFB-1451, Project 431549029-C07; Else Kr\u00f6ner-Fresenius-Stiftung Exzellenzstipendium (2022_EKES.23); \u201eBerta-Ottenstein-Program for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg\u201c, Forschungsstipendium. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Oberarzt in der Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Arbeitsgemeinschaft tiefe Hirnstimulation e.\u202fV., Tourette-Gesellschaft Deutschland e.\u202fV.\n                      S.\u00a0Rolker\n                      : A.\u00a0Finanzielle Interessen: S.\u00a0Rolker gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin, Sektion Interventionelle Biologische Psychiatrie, Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg.\n                      K.\u00a0Nickel\n                      : A.\u00a0Finanzielle Interessen: Deutsche Forschungsgemeinschaft (DFG), Projektnummer 551165096, Sachbeihilfe \u201eBerta-Ottenstein-Program for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg\u201c, Forschungsstipendium. \u2013\u00a0NAW (Notfallmedizinische Aus- und Weiterbildung) Berlin, Leiterin Kurs \u201ePraktische Konsiliar- und Liaisonpsychiatrie\u201c.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Fach\u00e4rztin f\u00fcr Psychiatrie und Psychotherapie, Funktionsober\u00e4rztin, Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg | Mitgliedschaften: DGPPN, Mitglied Referat Medizindidaktik, Mitglied Referat Psychosomatik, Sektion Konsiliar- und Liaisonpsychiatrie.\n                      K.\u00a0Domschke\n                      : A.\u00a0Finanzielle Interessen: Vortragshonorar Janssen-Cilag GmbH. \u2013\u00a0Mitglied \u201eNeurotorium\u201c Editorial Board, Lundbeck Foundation; Beirat des Freiburger Ausbildungsinstituts f\u00fcr Verhaltenstherapie.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztliche Direktorin der Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg | Vorstandsmitglied der Deutschen Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde.\n                      D.\u00a0Endres\n                      : A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung von der Deutschen Forschungsgemeinschaft (419859038) und dem Bundesministerium f\u00fcr Bildung und Forschung (01GM2208, CONNECT-GENERATE). \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender Oberarzt in der Klinik f\u00fcr Psychiatrie Psychotherapie des Universit\u00e4tsklinikums Freiburg | Referateleiter bei der DGBP.\n                      K.\u00a0M\u00fcller-Vahl\n                      : A.\u00a0Finanzielle Interessen: Kirsten M\u00fcller-Vahl has received financial or material research support from EU (FP7-HEALTH-2011 No. 278367, FP7-PEOPLE-2012-ITN No. 316978), DFG: GZ MU 1527\/3\u20111 and GZ MU 1527\/3\u20112, BMBF: 01KG1421, National Institute of Mental Health (NIMH), Tourette Gesellschaft Deutschland e.\u202fV., Else-Kr\u00f6ner-Fresenius-Stiftung, GW pharmaceuticals, Almirall, Abide Therapeutics, Emalex Biosciences, Inc., Noema Pharma, CannaXan, and Therapix Biosiences.\u00a0\u2013 She has received speaker\u2019s fees from Agaplesion Frankfurter Diakonie Kliniken gemeinn\u00fctzige GmbH, Almirall, Aphria Deutschland GmbH, Arbeitsgemeinschaft Cannabis als Medizin (ACM), Astra Zeneca, BDI Diaplan, Bedrocan, Bundesverband pharmazeutischer Cannabinoidunternehmen (BPC), Camurus, canymed GmbH, CEREBRO SPAIN BIDCO S.L, Cogitando GmbH, Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Diplomado Internacional de Endocannabinolog\u00eda (Programa Universitario de Investigaci\u00f3n en Salud \u2013\u00a0PUIS, UNAM), Dresden International University (DIU), Emalex, EpiCampusNord, Eurox Deutschland GmbH, Ever pharma GmbH, FOMF, Four20 Pharma, Georgia Medical Cannabis Project (GMCP), Grow Group PLC, Landesamt f\u00fcr Soziales, Jugend und Versorgung Mainz, Hessische Landesstelle f\u00fcr Suchtfragen e.\u202fV. (HLS), Laleto, Landschaftsverband Westfalen-Lippe, LIO Pharmaceuticals GmbH, Medizinischer Dienst Westfalen Lippe, Meinhardt Congress GmbH, PR Berater, RENAFAN, Salus gGmbH\u00a0\u2013 Fachklinikum Bernburg, Spectrum Therapeutics GmbH, streamedup! GmbH, Swiss Alpinopharm, SynopticCon GmbH, targoEvent GmbH, Takeda GmbH, Tilray, VFnK \u2013\u00a0Verein zur F\u00f6rderung neurologisch Kranker e.\u202fV., Verwaltungs-Berufsgenossenschaft (VBG), von Mende Marketing GmbH, Wayland Group, and WeCann.\u00a0\u2013 She has received consultant\u2019s and other honoraria from Abide Therapeutics, adjupharm, Alexion, AlphaSights Ltd., AMP Alternative Medical Products GmbH, Asavita GmbH, Aurora, Avextra, Becanex, Boehringer Ingelheim International GmbH, Bionorica Ethics GmbH, CannaMedical Pharma GmbH, Canopy Grouth, Cansativa, Columbia Care, CTC Communications Corp., DHMS Direct Health Medical Services Ltd., Demecan, Enua pharma, DHMS Direct Health Medical Services Ltd., Ethypharm GmbH, Eurox Group, Global Praxis Group Limited, Hormosan Pharma GmbH, Lundbeck, Marry Jane, MCI Germany, Merck, Neuraxpharm, Noema Pharma, Sanity Group, Stadapharm GmbH, Synendos Therapeutics AG, Syqe, Takeda, Tilray, and Zambon. | She is an advisory\/scientific board member for Alexion, Branchenverband Cannabiswirtschaft e.\u202fV. (BvCW), CannaMedical Pharma GmbH, Bionorica Ethics GmbH, CannaXan GmbH, Canopy Growth, Columbia Care, Ethypharm GmbH, Hormosan Pharma GmbH, IMC Germany, Leafly Deutschland GmbH, Neuraxpharm, Sanity Group, Stadapharm GmbH, Synendos Therapeutics AG, Syqe Medical Ltd., Therapix Biosciences Ltd., and Tilray. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrende Ober\u00e4rztin der Klinik f\u00fcr Psychiatrie, Sozialpsychiatrie und Psychotherapie, Medizinische Hochschule Hannover, Carl-Neuberg-Str.\u00a01, 30625 Hannover | seit 1994 Mitglied des wissenschaftlichen Beirats der \u201eTourette-Gesellschaft Deutschland e.\u202fV.\u201c (TGD) | seit 1997 Mitglied in der Tourette-Syndrome Association, Inc. (TSA), USA | seit 1999 Vorstandsmitglied der \u201eArbeitsgemeinschaft Cannabis als Medizin\u201c (ACM) | seit 1999 Mitglied in der Movement Disorder Society (MDS) | 2000 Gr\u00fcndungsmitglied der \u201eInternationalen Arbeitsgemeinschaft Cannabis als Medizin\u201c (IACM) | 2000\u20132007 2.\u00a0Vorsitzende der \u201eInternationalen Arbeitsgemeinschaft Cannabis als Medizin\u201c (IACM) | 2003\u20132004 Mitglied im \u201eInternational Steering Committee\u2013Tourette Syndrome International Database Consortium (TIC)\u201c | 2007\u20132009 1.\u00a0Vorsitzende der \u201eInternationalen Arbeitsgemeinschaft Cannabis als Medizin\u201c (IACM) | seit 2008 Mitglied in der \u201eEuropean Society for the Study of Tourette syndrome (ESSTS)\u201c | seit 2009 Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) | 2010\u20132014 Deutsche Vertreterin und Mitglied im Managementkommittee der EU gef\u00f6rderten COST Action BM0905\u00a0\u2013 European Network for the Study of Gilles de la Tourette Syndrome | 2011\u20132016 Vizepr\u00e4sidentin der \u201eEuropean Society for the Study of Tourette syndrome\u201c (ESSTS) | seit 2016 Mitglied im Sachverst\u00e4ndigenausschuss f\u00fcr Bet\u00e4ubungsmittel in der Bundesopiumstelle des Bundesinstituts f\u00fcr Arzneimittel und Medizinprodukte (BfArM) | 2017\u20132024 Mitglied im Medical Advisory Board (MAB) der Tourette Association of America (TAA) | 2017\u20132019 mehrfach t\u00e4tig als Einzelsachverst\u00e4ndige in Anh\u00f6rungen im Deutschen Bundestag zum \u201eCannabis-Gesetz\u201c | 2018 Sachverst\u00e4ndige in der Sitzung \u201eCannabis als Medikament und Fahreignung\u201c in der Bundesanstalt f\u00fcr Stra\u00dfenwesen (BAST) | seit 2019 1.\u00a0Vorsitzende der Arbeitsgemeinschaft Cannabis als Medizin (ACM) | 2019\u20132024 1.\u00a0Vorsitzende der \u201eInternationalen Arbeitsgemeinschaft Cannabis als Medizin\u201c (IACM) | 2020\u20132023 Pr\u00e4sidentin der \u201eEuropean Society for the Study of Tourette syndrome\u201c (ESSTS) | seit 2020 Mitglied in der Functional Neurological Disorder Society (FND) | seit 2020 Mitglied in der \u201eTic Disorders and Tourette Syndrome Study Group\u201c der Movement Disorder Society (MDS) | She has received royalties from\n                      Deutsches \u00c4rzteblatt\n                      , Neurologie und Psychiater, Elsevier, Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin, and Kohlhammer. | She served as a\u00a0guest editor for Frontiers in Neurology on the research topic \u201eThe neurobiology and genetics of Gilles de la Tourette syndrome: new avenues through large-scale collaborative projects\u201c, is an associate editor for \u201eCannabis and Cannabinoid Research\u201c and an Editorial Board Member of \u201eMedical Cannabis and Cannabinoids\u201c und \u201eMDPI-Reports\u201c and a\u00a0Scientific board member for\n                      Zeitschrift f\u00fcr Allgemeinmedizin\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}